One year in review 2018: novelties in the treatment of rheumatoid arthritis

被引：1
|
作者：
Bortoluzzi, A. [1 ]
Furini, F. [1 ]
Generali, E. [2 ]
Silvagni, E. [1 ]
Luciano, N. [3 ]
Scire, C. A. [1 ,4 ]
机构：
[1] Univ Ferrara, Rheumatol Unit, Dept Med Sci, Ferrara, Italy
[2] Humanitas Clin & Res Ctr, Div Rheumatol & Clin Immunol, Milan, Italy
[3] Univ Pisa, Rheumatol Unit, Dept Clin & Expt Med, Pisa, Italy
[4] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 03期
关键词：
rheumatoid arthritis; biologics; treatment; management; TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; LONG-TERM EFFECTIVENESS; RANDOMIZED PHASE IIB; LOW DISEASE-ACTIVITY; DOUBLE-BLIND; OPEN-LABEL; MONOCLONAL-ANTIBODY; CLINICAL-OUTCOMES; INADEQUATE RESPONSE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.
引用
下载
收藏
页码：347 / 361
页数：15
相关论文
共 50 条
  • [21] Novel insights into the management of rheumatoid arthritis: one year in review 2022
    Garaffoni, C.
    Adinolfi, A.
    Bortoluzzi, A.
    Filippou, G.
    Giollo, A.
    Sakellariou, G.
    Sirotti, S.
    Ughi, N.
    Scire, C. A.
    Silvagni, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (07) : 1247 - 1257
  • [22] Bone Effects of One-year Tofacitinib Treatment in Rheumatoid Arthritis
    Hamar, Attila
    Pusztai, Anita
    Vegh, Edit
    Horvath, Agnes
    Gulyas, Katalin
    Szamosi, Szilvia
    Petho, Zsofia
    Bodnar, Nora
    Soos, Boglarka
    Czokolyova, Monika
    Szanto, Sandor
    Szucs, Gabriella
    Bhattoa, Harjit
    Nagy, Gabor
    Tajti, Gabor
    Domjan, Andrea
    Hodosi, Katalin
    Szekanecz, Zoltan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] CHLOROQUINE IN RHEUMATOID ARTHRITIS - A DOUBLE BLINDFOLD TRIAL OF TREATMENT FOR ONE YEAR
    FREEDMAN, A
    STEINBERG, VL
    ANNALS OF THE RHEUMATIC DISEASES, 1960, 19 (03) : 243 - 250
  • [24] TNF Inhibitors for Rheumatoid Arthritis A Year in Review
    Simsek, Ismail
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2011, 69 (03): : 220 - 224
  • [25] One year in review 2018: gout
    Punzi, L.
    Scanu, A.
    Spinella, P.
    Galozzi, P.
    Oliviero, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01) : 1 - 11
  • [26] ADHERENCE OF INITIAL BIOLOGIC DURING THE SECOND YEAR IN RHEUMATOID ARTHRITIS PATIENTS WITH ONE YEAR OF EFFECTIVE TREATMENT
    Stolshek, B.
    De, A. P.
    Tang, D.
    Wade, S.
    Wade, R. L.
    Yeaw, J.
    VALUE IN HEALTH, 2016, 19 (03) : A235 - A235
  • [27] METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - A REVIEW OF RHEUMATOID-ARTHRITIS
    SAUVEZIE, B
    DUBOST, JJ
    GARANDEAU, A
    RAMPON, S
    REVUE DU RHUMATISME, 1987, 54 (7-9): : 607 - 615
  • [28] How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
    Torrente-Segarra, Vicenc
    Fernandez Prada, Manuel
    Exposito Moliner, Rosa
    Garrido Punal, Noemi Patricia
    Sanchez-Andrade Fernandez, Amalia
    Lamua Riazuelo, Jose Ramon
    Olive, Alejandro
    Tovar Beltran, Juan Victor
    Ferrandez, Jose Antonio Gonzalez
    Pastor, Carmen Moragues
    Arana, Ana Urruticoechea
    Rey, Jose Rey
    Cabello, Raul Veiga
    Diez, Angel Aragon
    Fuentes, Noelia Vazquez
    Cristobal, Anna Martinez
    Alonso, Ma del Pilar Navarro
    Palau, Sergi Ordonez
    Jimenez, Alejandro Munoz
    Martin, Jose Miguel Ruiz
    Pereira, Asuncion Acosta
    Aparicio, Angel Maria Garcia
    Fernandez, Jesus Carlos
    Morcillo, Mercedes
    Serret, Emilio Giner
    Palau, Nuria Montala
    Escalera, Carlos Rodriguez
    Esteban, Jose Campos
    de Oro, Juan Jose de Agustin
    Celimendiz, Pedro Giralt
    Vilchez, Desiree Ruiz
    Gonzalez-Albo, Silvia Paredes
    Courel, Laura Garrido
    Gonzalez, Carmen Olga Sanchez
    Guzman, Maria del Pilar Ahijado
    Perez, Patricia Castro
    Portales, Rosa Garcia
    Melon, Julia Fernandez
    Orfila, Gabriel Mercadal
    Pons, Jose Raul Noguera
    Tuduri, Concepcion Moll
    Armario, Ma Dolores Garcia
    Vila, Victor Eliseo Quevedo
    Garrido, Juan Jose Lerma
    Perez, Antonio Gracia
    Aguinaga, Elena Aurrecoechea
    Cid, Amalia Rueda
    Garcia, Marina Soledad Moreno
    Cortina, Eduardo Loza
    Torrent, Delia Taverner
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (02) : 395 - 398
  • [29] One year in review: ultrasound in arthritis
    Naredo, E.
    Iagnocco, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (01) : 1 - 10
  • [30] SECUKINUMAB TREATMENT PROVIDES SUSTAINED RESPONSE OVER ONE YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Durez, Patrick
    Genovese, Mark C.
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    RHEUMATOLOGY, 2012, 51 : 29 - 29
12345